Earlier studies in breast cancer TMA have shown good agreement of ER, PR, p53 and HER2 between TMA and large sections (Camp et al, 2000; Gillett et al, 2000; Torhorst et al, 2001). This evidence concerns the gene TP53 and breast cancer.